President's Council

Allison received her pharmacy doctorate from the University of New Mexico College of Pharmacy in 2003, then completed a general pharmacy practice residency at Boston Medical Center in 2004. She now serves as lead pharmacist of the Inpatient Antithrombosis Stewardship program at the University of New Mexico Health Sciences Center and as an associate adjunct clinical professor at the UNM College of Pharmacy. She has published more than 40 peer-reviewed articles and book chapters on anticoagulation, thrombosis and bleeding management and has presented on these same topics at numerous national and international conferences. She sits on the National Certification Board for Anticoagulation Providers and has the distinct honor of serving as the current president of the Anticoagulation Forum.

Jack Ansell, MD, MACP is former Chairman of Medicine, Lenox Hill Hospital and Professor of Medicine at Hofstra-Northwell School of Medicine. He is a clinical investigator with a principal focus on the clinical problems of thrombosis, antithrombotic therapy, and the application of new modes of delivering and monitoring anticoagulants. Prior to his position in New York, Dr. Ansell was a Professor of Medicine and Vice Chairman of the Department of Medicine at Boston University School of Medicine. Dr. Ansell has helped to identify and provide an understanding of the problems related to the management of warfarin therapy and was one of the first investigators to identify and show that patients can manage their own therapy through home monitoring. He has been a leader in the promotion of high quality anticoagulation management through the development of anticoagulation clinics and Dr. Ansell is the founder and past president of the Anticoagulation Forum, and he is past Chair of the Medical and Scientific Advisory Board of the National Blood Clot Alliance, a patient advocacy group. Dr. Ansell has authored over 220 peer reviewed manuscripts and over 50 textbook chapters and a number of texts. He has been the lead author for over 10 years of the major consensus guidelines for antithrombotic therapy through the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy, and is lead editor of a one-of-a- kind textbook entitled Managing Oral Anticoagulation: Clinical and Operational Guidelines. Dr. Ansell is a Master of the American College of Physicians and a Fellow of the American Heart Association. Dr. Ansell received his medical degree from the University Of Virginia School Of Medicine and completed his medical residency at Tufts-New England Medical Center in Boston, followed by a fellowship in Hematology at Boston University and the Boston’s Veterans Administration Hospital.

Mark Crowther, MD, MSc, FRCPC, received his M.D. from the University of Western Ontario in 1990. Dr Crowther’s research interests include exploring ways of improving the way that we use our current anticoagulant drugs. These include exploring established and novel interventions to mitigate bleeding, and studies of currently available anticoagulant drugs in high-risk patient populations. Dr Crowther’s work also focusses on developing systematic reviews of key questions in Hematology and Thrombosis, and basing Guidelines on those reviews. Dr Crowther has more than 400 peer reviewed publications, was inducted into the Royal Society of Canada in 2017, and received the 2017 International Society of Thrombosis and Haemostasis BACH Investigator Recognition Award. He was one of 14 scientists from the Michael G. DeGroote School of Medicine at McMaster University cited by Clarivate Analytics on its Highly Cited Researchers list (formerly known as Thomson Reuter's annual publication of The World's Most Influential Scientific Minds). Dr Crowther is currently the Chair, Department of Medicine at McMaster University and holds the Leo Pharma Chair in Thromboembolism Research at McMaster University.

David Garcia, MD completed internal medicine residency at The Johns Hopkins Hospital and hematology fellowship at the University of Washington. He has been Professor of Medicine in the Division of Hematology at the University of Washington since 2013. Dr. Garcia has been either an investigator or steering committee member for numerous clinical trials related to the prevention and treatment of thromboembolic disease, and he is a past-President of the Anticoagulation Forum. In addition to being a current member of the AC Forum Board of Directors, Dr. Garcia is the senior Co-director for the American Society of Hematology’s Clinical Research Training Institute and was the 2017 Chairman of the ASH Scientific Committee on Thrombosis and Vascular Biology. Dr. Garcia has authored or co-authored more than 90 peer-reviewed publications in journals such as Blood, Archives of Internal Medicine, New England Journal of Medicine, the British Journal of Hematology, Stroke, and Circulation, has been involved with the development of international guidelines, and has served in an editorial capacity for several high-impact publications such as Blood and ACP Journal Club.

Scott Kaatz is Clinical Professor of Medicine at Michigan State University College of Human Medicine and Wayne State University School of Medicine and a Hospitalist at Henry Ford Hospital in Detroit where he serves as the Medical Director for Professional Development and Research in the Division of Hospital Medicine. He attended medical school at Michigan State University and completed his residency in internal medicine at Henry Ford Hospital. Later in his career, he earned his master’s degree in Evidence-Based Health Care from Oxford University. He has a long-standing research interest in anticoagulation and thromboembolic disease and was the Medical Director of the Anticoagulation Clinics for the Henry Ford Health System in Detroit, MI for15 years. Dr. Kaatz is a Fellow of American College of Physicians and a Senior Fellow Society of Hospital Medicine. He is a past President of the Anticoagulation Forum, Thrombosis and Hemostasis Societies of North America and the Michigan Chapter of the Society of Hospital Medicine. He also serves on the Medical Scientific Advisory Board of the National Blood Clot Alliance and the Board of the PERT Consortium and has served on the National Certification Board of Anticoagulation Providers. He has participated in many research studies with an emphasis on anticoagulation, atrial fibrillation, peri-procedural anticoagulation and venous thromboembolism prevention, diagnosis, and treatment; and has published over 300, articles, book chapters and abstracts in this field.